Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04521881
PHASE3

Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults

Sponsor: London School of Hygiene and Tropical Medicine

View on ClinicalTrials.gov

Summary

Tranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury

Official title: Intramuscular Tranexamic Acid for the Treatment of Symptomatic Mild Traumatic Brain Injury in Older Adults: a Randomised, Double-blind, Placebo-controlled Trial

Key Details

Gender

All

Age Range

50 Years - Any

Study Type

INTERVENTIONAL

Enrollment

5000

Start Date

2021-04-18

Completion Date

2028-01-31

Last Updated

2026-03-12

Healthy Volunteers

No

Interventions

DRUG

Tranexamic Acid 500 MG

given once as an intramuscular injection

Locations (2)

The Royal London Hospital

London, London, United Kingdom

St George's Hospital

London, London, United Kingdom